In a significant breakthrough against antibiotic resistance, artificial intelligence has identified two new compounds effective against drug-resistant gonorrhoea and MRSA. This achievement, detailed by BBC, traditionally requires years of human research, underscoring AI's capacity to accelerate critical medical advancements. Such rapid identification of novel compounds represents a new frontier in combating global health threats.

However, AI's demonstrated speed and accuracy in drug discovery and diagnostics are contrasted by concerning rates of hallucination and bias when applied to complex scientific literature analysis. This dichotomy presents a tension between AI's potential for breakthroughs and its inherent limitations in nuanced interpretation.

Based on AI's current capabilities and limitations, healthcare will likely see a hybrid future where AI excels in specific, high-volume tasks, while human experts remain indispensable for nuanced interpretation, ethical oversight, and mitigating inherent AI biases.

Artificial intelligence is being used to invent new drugs for diseases such as Parkinson's disease and antibiotic-resistant superbugs, according to BBC. AI can screen massive libraries of chemical compounds in a matter of days or hours to identify those with antibacterial activity. This capacity to swiftly analyze vast datasets promises a new era of medical breakthroughs, reshaping how we approach disease treatment and prevention.

Quantifying AI's Efficiency in Research

  • 80–94% — data extraction accuracy achieved by Large Language Models (LLMs) in systematic reviews, according to pmc (2026).
  • 40% — reduction in screening workload in systematic reviews achieved by LLMs, according to pmc.

These figures indicate that AI-powered tools can significantly reduce the manual burden and improve the initial accuracy of data handling in scientific literature reviews, freeing human researchers for more complex analytical tasks. The efficiency gains could accelerate the preliminary stages of research, allowing faster progression to critical evaluation.